(CNN) -- The U.S. Food and Drug Administration has levied a $4.2 million fine against the American Red Cross, saying it has failed to comply with laws and regulations relating to the collection of blood products, the FDA said in a
written statement Friday.
The violations included failing to ask appropriate donor screening questions and failure to follow manufacturer test protocols, the FDA said. The agency said it has no evidence that the violations resulted in "serious health consequences." (
Full story)
The fine stems from a recent FDA review of Red Cross recalls between 2003 and 2005, the FDA said. The review found "these events were preventable."
